Introduction to AccuBio
Thank you for your interest in working for AccuBio Limited!
AccuBio is a UK based company (2022), wholly owned by Zhejiang Orient Gene Biotech, who were formed in 2005.
Our company vision is to become a great enterprise in the field of global in-vitro diagnostics, that integrates global science and technology to provide health diagnosis and support for life.
AccuBio has established a base in Alva, Scotland following the acquisition of the Omega Diagnostics facility, securing the site and 100+ jobs. We have exciting investment plans to grow the UK business, with an initial investment of £5m, to increase production of lateral flow test devices to 2m tests per week, covering different disease types and applications.
Our initial focus has been to produce COVID antigen tests and we will expand into other infectious disease and cardiovascular products. We recently purchased VISITECT CD4 from Omega Diagnostics as part of our infectious disease strategy for developing countries.
Our Senior Management Team
Colin King
Colin King
Colin King is our President and has over 25 years’ experience in the Diagnostics industry of which 15 spent leading companies. I enjoy setting the strategic direction for companies and supporting management and staff to deliver on the agreed strategic objectives, whilst seeing individuals grow within the company.
We use cookies to allow our website to function properly, provide social media functionality, and analyze traffic. We also share information with our partners about your use of our website.